AERT Stock Edges Up 3% Ahead of Holiday Weekend, Faces AI Drive and Nasdaq Risk

May 23, 2026
AERT Stock Edges Up 3% Ahead of Holiday Weekend, Faces AI Drive and Nasdaq Risk

NEW YORK, May 23, 2026, 09:02 EDT

  • Aeries Technology finished Friday at 71 cents, falling 1.99% for the session. Shares are still up roughly 2.9% versus last Friday.
  • Nasdaq won’t trade this weekend and stays closed Monday, May 25, for Memorial Day.
  • The stock is still trading under Nasdaq’s $1 minimum, so the listing risk is still there.

Aeries Technology stock finished the week in the green. Shares dropped Friday, but traders still looked at a new AI platform launch, the price stuck below $1 and Nasdaq listing problems that aren’t yet resolved.

AERT slipped 1.99% to end Friday at $0.710, moving between $0.700 and $0.760 over the session. Shares are still up about 2.9% from the May 15 close of $0.690. Friday’s volume was 120,800 shares. The company’s market cap was about $34.6 million, leaving it as one of the smaller, lightly traded stocks in the U.S. market.

Tight timing for traders. U.S. stock markets are shut over the weekend, with Nasdaq listing Memorial Day, May 25, as a holiday. Trading is set to pick back up on Tuesday, May 26.

Aeries this week launched its A1 GCC platform on May 18, targeting Global Capability Centers—offshore and nearshore teams that run tech, operations, and support for companies. The company described A1 GCC as an “agentic AI” platform that uses AI agents to manage tasks, create summaries, and push follow-ups across different work areas. Aeries Technology, Inc.

Aeries chief technology officer Unni Nambiar said the platform aims to give teams “greater clarity, speed, and control.” Aeries said A1 GCC is designed to sit above tools like ERP, CRM, and HR systems, not to replace them. Aeries Technology, Inc.

U.S. stocks finished their eighth week of gains, though the tape only carried things so far. The S&P 500 added 0.9% for the week, the Nasdaq Composite gained 0.5%, and the Russell 2000 jumped 2.7%, according to the Associated Press.

Aeries is looking to carve out a spot in the packed services field. Infosys is selling its AI-first GCC offerings, while Cognizant says it helps firms modernize tech and change up processes. Accenture is in the mix across technology transformation and managed services. Aeries is making a more focused pitch: it wants to build and run GCCs for private equity portfolio firms and big company clients.

Aeries’s most recent quarter sheds light on the stock’s performance. For the quarter ended Dec. 31, the company posted $17.5 million in revenue, net income of $1.2 million and adjusted EBITDA of $2.5 million. Adjusted EBITDA removes interest, taxes, depreciation, amortization, and other items, according to the company.

Aeries CEO Ajay Khare said in the February statement that the company had “stable revenue” and “positive operating cash flow.” Aeries is targeting fiscal 2027 revenue between $80 million and $84 million, with adjusted EBITDA in a range of $10 million to $12 million. GlobeNewswire

Aeries faces possible delisting. The company said in an April 3 filing that Nasdaq staff had warned it about not meeting the $1 minimum bid-price rule, which says a stock has to stay above a $1 bid. Aeries said it would ask for a hearing to pause any next step, but also warned there’s no guarantee the panel will let the listing stand.

Aeries shareholders signed off on a reverse split in March, giving the board power to consolidate at a ratio of up to 1-for-10 and raise the stock price by combining shares. But Aeries said at that time it wasn’t planning to use that authority in the near term.

AERT investors will be watching Tuesday’s post-holiday open, waiting on any Nasdaq hearing news, and looking for signs in the A1 GCC launch of fresh customer wins. Shares are above their February bottom but at 71 cents, the listing issue still lingers.

Stock Market Today

  • Australia Aspirin Market 2026-2035: Growth in Low-Dose Cardiovascular Segment amid Import Dependency
    May 23, 2026, 11:25 AM EDT. The Australia aspirin market is evolving, with low-dose (81 mg) formulations for cardiovascular prevention driving volume growth to 40-45% of unit sales by 2026. Private-label aspirin captures 25-30% of retail volume, pressuring branded producers amid a 50-60% price gap. The market depends on imports for over 90% of acetylsalicylic acid active pharmaceutical ingredient (API), mainly from China and India, exposing it to supply and cost volatility with input prices up 12-18% in 18 months. Aging demographics boost demand for prophylactic aspirin at 3-5% annual growth, outpacing traditional pain relief. Consumer trends favor coated and combination tablets now 20% of revenues. Online sales channels are expanding, making up 12-15% of volume. Challenges include regulatory costs, API price swings, stockouts, and retail consolidation squeezing supplier margins and innovation.